CVE-2023-0221

MEDIUMCVSS 4.4/10EPSS 0.18%

Last modified

CVE-2023-0221 is a medium-severity vulnerability rated 4.4/10 on the CVSS scale. Product security bypass vulnerability in ACC prior to version 8.3.4 allows a locally logged-in attacker with administrator privileges to bypass the execution controls provided by ACC using the utilman program. . EPSS estimates a 0.18% chance of exploitation in the next 30 days.

Description

Product security bypass vulnerability in ACC prior to version 8.3.4 allows a locally logged-in attacker with administrator privileges to bypass the execution controls provided by ACC using the utilman program.

Metrics

CVSS 3.1
4.4/10

CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N

EPSS Probability
0.18%

8.1th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
McafeeApplication And Change Control< 8.3.4

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-0221?
Product security bypass vulnerability in ACC prior to version 8.3.4 allows a locally logged-in attacker with administrator privileges to bypass the execution controls provided by ACC using the utilman program.
How severe is CVE-2023-0221?
CVE-2023-0221 has a CVSS score of 4.4/10 (MEDIUM severity). The EPSS model estimates a 0.18% probability of exploitation in the next 30 days.
How do I fix CVE-2023-0221?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-0221?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST